Clindamycin Adult Dosage
For adults, the standard clindamycin dosage is 150-450 mg orally every 6-8 hours for mild-to-moderate infections, or 600-900 mg intravenously every 6-8 hours for serious infections, with the specific dose and route determined by infection severity and pathogen susceptibility.
Oral Dosing
Standard oral dosing ranges from 150-450 mg every 6 hours (four times daily) 1, 2. The FDA-approved labeling supports this dosing for typical bacterial infections. For most skin and soft tissue infections caused by susceptible organisms, 300-450 mg four times daily is appropriate 3.
- Mild infections: 150-300 mg every 6 hours
- Moderate infections: 300-450 mg every 6 hours
- Maximum oral dose: 450 mg per dose, up to 1800 mg/day
The oral bioavailability is approximately 87.6%, making oral administration highly effective when appropriate 4. However, food does not significantly impair absorption, though it may slightly delay peak concentrations 5.
Intravenous Dosing
For serious infections requiring parenteral therapy, the recommended IV dose is 600-900 mg every 6-8 hours 1.
Dosing by Severity:
- Moderate-to-severe infections: 600 mg IV every 8 hours
- Severe or life-threatening infections: 900 mg IV every 8 hours (or 600 mg every 6 hours)
- Maximum daily dose: 4800 mg/day
The 900 mg every 8 hours regimen is pharmacokinetically equivalent to 600 mg every 6 hours and provides significantly higher cure rates for intraabdominal infections (90.5% vs 75.6%) 6, 7. For serious obstetric and gynecologic infections, 900 mg IV every 8 hours is the recommended standard 8.
Weight-Based Considerations:
For patients weighing >75 kg, consider increasing the dose to 900 mg every 8 hours to maintain adequate trough concentrations (Cmin ≥2 mg/L) 4. Body weight significantly affects clindamycin clearance, necessitating dose adjustments in heavier patients.
Specific Clinical Scenarios
Skin and Soft Tissue Infections (SSTI):
- MRSA infections: 600 mg IV every 8 hours or 300-450 mg orally four times daily 3
- Methicillin-susceptible S. aureus: 600 mg IV every 8 hours or 300-450 mg orally four times daily 3
Important Caveats:
When combined with rifampicin, oral clindamycin is contraindicated due to dramatically reduced bioavailability (dropping to 4-11% depending on rifampicin dose). If this combination is necessary, use IV clindamycin at doses of at least 3600-4800 mg/day, preferably by continuous infusion 9.
In renal failure, no dose adjustment is required as clindamycin is not significantly renally eliminated 10. The drug maintains normal pharmacokinetics even in patients on hemodialysis, and standard adult doses (150-300 mg four times daily) can be given safely.
Administration Guidelines:
- IV infusions should be administered over 10-60 minutes to minimize infusion-related reactions 1
- Monitor for Clostridioides difficile-associated diarrhea, particularly in elderly patients (>60 years), who have higher risk 1, 2
- Avoid rapid IV bolus administration due to potential cardiac effects
- Continuous infusion may be superior to intermittent dosing for maintaining therapeutic concentrations, especially when targeting organisms with MIC at the EUCAST breakpoint (0.25 mg/L for S. aureus) 9
Duration of Therapy:
Typical treatment courses range from 7-10 days depending on clinical response, though specific infections may require longer therapy 3. Always complete the full prescribed course to prevent resistance development 1, 2.